Yi-jung Huang

No 100 Shih Chuan 1st Road
Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy.

Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy.

Journal: International journal of biological macromolecules
Published: February 26, 2026

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Journal: International journal of biological macromolecules
Published: October 12, 2024

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

Journal: International journal of biological macromolecules
Published: September 20, 2024

Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection.

Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection.

Journal: Journal of virology
Published: March 28, 2024

Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab.

Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab.

Journal: International journal of biological macromolecules
Published: September 20, 2023

XPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer.

XPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer.

Journal: Cells
Published: March 29, 2023

Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.

Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.

Journal: Virus research
Published: December 30, 2022

ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells.

ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells.

Journal: Cancers
Published: July 11, 2022

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer.

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer.

Journal: Cancers
Published: June 29, 2022

Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probe.

Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probe.

Journal: Frontiers in microbiology
Published: March 15, 2022

Health-Promoting Lifestyle and Its Predictors in Adolescent Survivors of Childhood Cancer.

Health-Promoting Lifestyle and Its Predictors in Adolescent Survivors of Childhood Cancer.

Journal: Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
Published: February 17, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026